This study is accepting new patients by invitation only
Health eHeart BioBank
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Healthy Volunteers
- healthy people welcome
- Location
- at UCSF
- Dates
- study startedcompletion around
- Principal Investigator
- by Jeffrey E Olgin, MD (ucsf)Gregory Marcus, MD (ucsf)Vasanth Vedantham, MD (ucsf)Connor G O'Brien, MD (ucsf)James P Pirruccello, MD (ucsf)
Description
Summary
Keywords
Eligibility
Location
Lead Scientists at University of California Health
- Jeffrey E Olgin, MD (ucsf)
Dr. Olgin is a Cardiologist and a Cardiac Electrophysiologist. His main clinical interests include conduction disorders, arrhythmias, catheter ablation, implantable devices—pacemakers and defibrillators, atrial fibrillation, atrial flutter, ventricular tachycardia, sudden death and supraventricular tachycardia. - Gregory Marcus, MD (ucsf)
Dr. Gregory Marcus is a specialist in the treatment of arrhythmias, including mapping and catheter ablation for atrial fibrillation, supraventricular tachycardias and ventricular arrhythmias. He is also an expert in pacemaker, biventricular device and defibrillator implantation. RESEARCH Dr. Marcus is Associate Chief of Cardiology for Research at UCSF Health. He is also an Ass… - Vasanth Vedantham, MD (ucsf)
Dr. Vedantham is cardiologist and clinical cardiac electrophysiologist, specializing in treatment of heart rhythm disorders using catheter ablation, pacemaker and defibrillator implantation, and antiarrhythmic medications. - Connor G O'Brien, MD (ucsf)
- James P Pirruccello, MD (ucsf)
Interested in the prevention of cardiac and aortic diseases, and in the use of genetic information to inform cardiovascular care. Dr. Pirruccello studies cardiovascular and aortic diseases using machine learning and genetics. He uses machine learning to quantify the heart, and to create new types of measurements that can help us to better understand health and disease.
Details
- Status
- accepting new patients by invitation only
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Francisco
- ID
- NCT06976502
- Study Type
- Observational [Patient Registry]
- Participants
- Expecting 500000 study participants
- Last Updated